nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—FGFR3—skull—pharynx cancer	0.0484	0.0969	CbGeAlD
Ponatinib—FGFR2—skull—pharynx cancer	0.0317	0.0634	CbGeAlD
Ponatinib—FGFR4—brainstem—pharynx cancer	0.016	0.0321	CbGeAlD
Ponatinib—FGFR2—mouth—pharynx cancer	0.011	0.022	CbGeAlD
Ponatinib—BCR—parotid gland—pharynx cancer	0.0101	0.0202	CbGeAlD
Ponatinib—RET—neck—pharynx cancer	0.00986	0.0198	CbGeAlD
Ponatinib—FGFR3—epithelium—pharynx cancer	0.00974	0.0195	CbGeAlD
Ponatinib—BCR—saliva-secreting gland—pharynx cancer	0.00966	0.0194	CbGeAlD
Ponatinib—FGFR2—neck—pharynx cancer	0.00937	0.0188	CbGeAlD
Ponatinib—FGFR4—head—pharynx cancer	0.00886	0.0178	CbGeAlD
Ponatinib—KIT—mouth—pharynx cancer	0.00761	0.0152	CbGeAlD
Ponatinib—LYN—lymphoid tissue—pharynx cancer	0.00754	0.0151	CbGeAlD
Ponatinib—BCR—trachea—pharynx cancer	0.00745	0.0149	CbGeAlD
Ponatinib—KDR—neck—pharynx cancer	0.00734	0.0147	CbGeAlD
Ponatinib—FGFR2—saliva-secreting gland—pharynx cancer	0.00731	0.0146	CbGeAlD
Ponatinib—FGFR2—brainstem—pharynx cancer	0.00716	0.0143	CbGeAlD
Ponatinib—FGFR3—spinal cord—pharynx cancer	0.0068	0.0136	CbGeAlD
Ponatinib—RET—epithelium—pharynx cancer	0.00671	0.0134	CbGeAlD
Ponatinib—KIT—neck—pharynx cancer	0.00651	0.013	CbGeAlD
Ponatinib—BCR—lymphoid tissue—pharynx cancer	0.00649	0.013	CbGeAlD
Ponatinib—FLT3—lymphoid tissue—pharynx cancer	0.00645	0.0129	CbGeAlD
Ponatinib—FGFR2—epithelium—pharynx cancer	0.00638	0.0128	CbGeAlD
Ponatinib—FGFR4—lymph node—pharynx cancer	0.0062	0.0124	CbGeAlD
Ponatinib—TEK—epithelium—pharynx cancer	0.00611	0.0122	CbGeAlD
Ponatinib—LYN—head—pharynx cancer	0.00608	0.0122	CbGeAlD
Ponatinib—FGFR3—head—pharynx cancer	0.00604	0.0121	CbGeAlD
Ponatinib—KDR—parotid gland—pharynx cancer	0.00598	0.012	CbGeAlD
Ponatinib—LCK—trachea—pharynx cancer	0.00593	0.0119	CbGeAlD
Ponatinib—BCR—spinal cord—pharynx cancer	0.00589	0.0118	CbGeAlD
Ponatinib—KDR—saliva-secreting gland—pharynx cancer	0.00573	0.0115	CbGeAlD
Ponatinib—SRC—epithelium—pharynx cancer	0.00543	0.0109	CbGeAlD
Ponatinib—KIT—parotid gland—pharynx cancer	0.0053	0.0106	CbGeAlD
Ponatinib—FGFR1—spinal cord—pharynx cancer	0.00524	0.0105	CbGeAlD
Ponatinib—BCR—head—pharynx cancer	0.00523	0.0105	CbGeAlD
Ponatinib—RET—lymphoid tissue—pharynx cancer	0.00517	0.0104	CbGeAlD
Ponatinib—KIT—saliva-secreting gland—pharynx cancer	0.00508	0.0102	CbGeAlD
Ponatinib—KDR—epithelium—pharynx cancer	0.005	0.01	CbGeAlD
Ponatinib—KIT—brainstem—pharynx cancer	0.00497	0.00996	CbGeAlD
Ponatinib—PDGFRA—trachea—pharynx cancer	0.0049	0.00981	CbGeAlD
Ponatinib—TEK—lymphoid tissue—pharynx cancer	0.00471	0.00943	CbGeAlD
Ponatinib—RET—spinal cord—pharynx cancer	0.00469	0.00939	CbGeAlD
Ponatinib—ABL1—parotid gland—pharynx cancer	0.00461	0.00924	CbGeAlD
Ponatinib—FGFR2—spinal cord—pharynx cancer	0.00445	0.00892	CbGeAlD
Ponatinib—KIT—epithelium—pharynx cancer	0.00443	0.00887	CbGeAlD
Ponatinib—ABL1—saliva-secreting gland—pharynx cancer	0.00442	0.00885	CbGeAlD
Ponatinib—KDR—trachea—pharynx cancer	0.00442	0.00885	CbGeAlD
Ponatinib—ABL1—brainstem—pharynx cancer	0.00433	0.00867	CbGeAlD
Ponatinib—TEK—spinal cord—pharynx cancer	0.00427	0.00855	CbGeAlD
Ponatinib—PDGFRA—lymphoid tissue—pharynx cancer	0.00427	0.00855	CbGeAlD
Ponatinib—SRC—lymphoid tissue—pharynx cancer	0.00418	0.00838	CbGeAlD
Ponatinib—RET—head—pharynx cancer	0.00416	0.00834	CbGeAlD
Ponatinib—FGFR2—head—pharynx cancer	0.00396	0.00793	CbGeAlD
Ponatinib—KIT—trachea—pharynx cancer	0.00392	0.00784	CbGeAlD
Ponatinib—PDGFRA—spinal cord—pharynx cancer	0.00387	0.00775	CbGeAlD
Ponatinib—KDR—lymphoid tissue—pharynx cancer	0.00385	0.00771	CbGeAlD
Ponatinib—TEK—head—pharynx cancer	0.00379	0.0076	CbGeAlD
Ponatinib—SRC—spinal cord—pharynx cancer	0.00379	0.0076	CbGeAlD
Ponatinib—BCR—lymph node—pharynx cancer	0.00366	0.00734	CbGeAlD
Ponatinib—FLT3—lymph node—pharynx cancer	0.00364	0.00729	CbGeAlD
Ponatinib—KDR—spinal cord—pharynx cancer	0.00349	0.00699	CbGeAlD
Ponatinib—PDGFRA—head—pharynx cancer	0.00344	0.00689	CbGeAlD
Ponatinib—KIT—lymphoid tissue—pharynx cancer	0.00341	0.00683	CbGeAlD
Ponatinib—ABL1—trachea—pharynx cancer	0.00341	0.00683	CbGeAlD
Ponatinib—SRC—head—pharynx cancer	0.00337	0.00675	CbGeAlD
Ponatinib—FGFR1—lymph node—pharynx cancer	0.00326	0.00653	CbGeAlD
Ponatinib—KDR—head—pharynx cancer	0.0031	0.00621	CbGeAlD
Ponatinib—KIT—spinal cord—pharynx cancer	0.00309	0.00619	CbGeAlD
Ponatinib—ABL1—lymphoid tissue—pharynx cancer	0.00297	0.00595	CbGeAlD
Ponatinib—RET—lymph node—pharynx cancer	0.00292	0.00584	CbGeAlD
Ponatinib—LCK—lymph node—pharynx cancer	0.00292	0.00584	CbGeAlD
Ponatinib—ABCG2—parotid gland—pharynx cancer	0.00291	0.00583	CbGeAlD
Ponatinib—ABCG2—saliva-secreting gland—pharynx cancer	0.00279	0.00558	CbGeAlD
Ponatinib—KIT—head—pharynx cancer	0.00275	0.00551	CbGeAlD
Ponatinib—ABL1—spinal cord—pharynx cancer	0.00269	0.00539	CbGeAlD
Ponatinib—TEK—lymph node—pharynx cancer	0.00266	0.00532	CbGeAlD
Ponatinib—PDGFRA—lymph node—pharynx cancer	0.00241	0.00482	CbGeAlD
Ponatinib—ABL1—head—pharynx cancer	0.00239	0.00479	CbGeAlD
Ponatinib—SRC—lymph node—pharynx cancer	0.00236	0.00473	CbGeAlD
Ponatinib—KDR—lymph node—pharynx cancer	0.00217	0.00435	CbGeAlD
Ponatinib—KIT—lymph node—pharynx cancer	0.00192	0.00386	CbGeAlD
Ponatinib—CYP2D6—brainstem—pharynx cancer	0.00187	0.00375	CbGeAlD
Ponatinib—ABCG2—spinal cord—pharynx cancer	0.0017	0.0034	CbGeAlD
Ponatinib—ABL1—lymph node—pharynx cancer	0.00167	0.00336	CbGeAlD
Ponatinib—ABCB1—epithelium—pharynx cancer	0.0012	0.0024	CbGeAlD
Ponatinib—ABCB1—trachea—pharynx cancer	0.00106	0.00212	CbGeAlD
Ponatinib—ABCG2—lymph node—pharynx cancer	0.00106	0.00212	CbGeAlD
Ponatinib—CYP2D6—head—pharynx cancer	0.00103	0.00207	CbGeAlD
Ponatinib—ABCB1—lymphoid tissue—pharynx cancer	0.000923	0.00185	CbGeAlD
Ponatinib—ABCB1—spinal cord—pharynx cancer	0.000837	0.00168	CbGeAlD
Ponatinib—ABCB1—head—pharynx cancer	0.000744	0.00149	CbGeAlD
Ponatinib—FGFR3—Immune System—CD79A—pharynx cancer	0.000536	0.00107	CbGpPWpGaD
Ponatinib—FGFR1—Downstream signal transduction—EGFR—pharynx cancer	0.000534	0.00107	CbGpPWpGaD
Ponatinib—PDGFRA—Downstream signal transduction—EGFR—pharynx cancer	0.000533	0.00106	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by FGFR—EGFR—pharynx cancer	0.000531	0.00106	CbGpPWpGaD
Ponatinib—FGFR2—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000531	0.00106	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000531	0.00106	CbGpPWpGaD
Ponatinib—FGFR2—DAP12 interactions—EGFR—pharynx cancer	0.000531	0.00106	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by FGFR—EGFR—pharynx cancer	0.00053	0.00106	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by ERBB2—EGFR—pharynx cancer	0.000529	0.00106	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by ERBB2—EGFR—pharynx cancer	0.000527	0.00105	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by EGFR—EGFR—pharynx cancer	0.000526	0.00105	CbGpPWpGaD
Ponatinib—FGFR1—DAP12 signaling—EGFR—pharynx cancer	0.000526	0.00105	CbGpPWpGaD
Ponatinib—FGFR3—Signaling by NGF—EGFR—pharynx cancer	0.000526	0.00105	CbGpPWpGaD
Ponatinib—PDGFRA—DAP12 signaling—EGFR—pharynx cancer	0.000525	0.00105	CbGpPWpGaD
Ponatinib—LYN—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000522	0.00104	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000522	0.00104	CbGpPWpGaD
Ponatinib—KIT—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000522	0.00104	CbGpPWpGaD
Ponatinib—KIT—DAP12 interactions—EGFR—pharynx cancer	0.000522	0.00104	CbGpPWpGaD
Ponatinib—KIT—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000522	0.00104	CbGpPWpGaD
Ponatinib—ABCB1—lymph node—pharynx cancer	0.000521	0.00104	CbGeAlD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00052	0.00104	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by PDGF—EGFR—pharynx cancer	0.000519	0.00104	CbGpPWpGaD
Ponatinib—FGFR1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000519	0.00104	CbGpPWpGaD
Ponatinib—PDGFRA—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000517	0.00103	CbGpPWpGaD
Ponatinib—KIT—Signaling by EGFR—EGFR—pharynx cancer	0.000517	0.00103	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—EGFR—pharynx cancer	0.000516	0.00103	CbGpPWpGaD
Ponatinib—SRC—L1CAM interactions—EGFR—pharynx cancer	0.000515	0.00103	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—B4GALT5—pharynx cancer	0.000513	0.00102	CbGpPWpGaD
Ponatinib—KIT—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000512	0.00102	CbGpPWpGaD
Ponatinib—KIT—Signaling by PDGF—EGFR—pharynx cancer	0.00051	0.00102	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—CCND1—pharynx cancer	0.000509	0.00102	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CD79A—pharynx cancer	0.000499	0.000996	CbGpPWpGaD
Ponatinib—FGFR1—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000495	0.000988	CbGpPWpGaD
Ponatinib—FGFR1—DAP12 interactions—EGFR—pharynx cancer	0.000495	0.000988	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000495	0.000988	CbGpPWpGaD
Ponatinib—PDGFRA—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000494	0.000986	CbGpPWpGaD
Ponatinib—PDGFRA—DAP12 interactions—EGFR—pharynx cancer	0.000494	0.000986	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000494	0.000986	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—CDH1—pharynx cancer	0.000493	0.000983	CbGpPWpGaD
Ponatinib—ABL1—Integrated Breast Cancer Pathway—EGFR—pharynx cancer	0.000492	0.000982	CbGpPWpGaD
Ponatinib—FGFR2—B Cell Activation—EGFR—pharynx cancer	0.000491	0.000981	CbGpPWpGaD
Ponatinib—SRC—GAB1 signalosome—EGFR—pharynx cancer	0.000491	0.00098	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.000491	0.00098	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by EGFR—EGFR—pharynx cancer	0.000491	0.000979	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by EGFR—EGFR—pharynx cancer	0.000489	0.000977	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000486	0.000971	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000485	0.000968	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by PDGF—EGFR—pharynx cancer	0.000484	0.000966	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by PDGF—EGFR—pharynx cancer	0.000483	0.000964	CbGpPWpGaD
Ponatinib—KIT—B Cell Activation—EGFR—pharynx cancer	0.000483	0.000963	CbGpPWpGaD
Ponatinib—SRC—ErbB1 downstream signaling—EGFR—pharynx cancer	0.00048	0.000958	CbGpPWpGaD
Ponatinib—FGFR2—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00047	0.000939	CbGpPWpGaD
Ponatinib—PDGFRA—Focal Adhesion—EGFR—pharynx cancer	0.000466	0.000931	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000466	0.00093	CbGpPWpGaD
Ponatinib—ABL1—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.000465	0.000929	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000465	0.000927	CbGpPWpGaD
Ponatinib—KIT—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000462	0.000922	CbGpPWpGaD
Ponatinib—FGFR1—B Cell Activation—EGFR—pharynx cancer	0.000458	0.000914	CbGpPWpGaD
Ponatinib—PDGFRA—B Cell Activation—EGFR—pharynx cancer	0.000457	0.000912	CbGpPWpGaD
Ponatinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—pharynx cancer	0.000449	0.000897	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—CNDP2—pharynx cancer	0.000447	0.000893	CbGpPWpGaD
Ponatinib—FGFR1—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000438	0.000875	CbGpPWpGaD
Ponatinib—PDGFRA—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000437	0.000873	CbGpPWpGaD
Ponatinib—LYN—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000435	0.000869	CbGpPWpGaD
Ponatinib—FGFR1—MAPK Signaling Pathway—TP53—pharynx cancer	0.000433	0.000865	CbGpPWpGaD
Ponatinib—LCK—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000428	0.000855	CbGpPWpGaD
Ponatinib—LCK—Disease—B4GALT5—pharynx cancer	0.000418	0.000834	CbGpPWpGaD
Ponatinib—KDR—Axon guidance—EGFR—pharynx cancer	0.000415	0.000828	CbGpPWpGaD
Ponatinib—ABL1—Integrated Breast Cancer Pathway—TP53—pharynx cancer	0.000413	0.000825	CbGpPWpGaD
Ponatinib—LCK—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00041	0.000818	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CD79A—pharynx cancer	0.000409	0.000816	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000408	0.000814	CbGpPWpGaD
Ponatinib—TEK—Hemostasis—TP53—pharynx cancer	0.000407	0.000812	CbGpPWpGaD
Ponatinib—FGFR4—Innate Immune System—EGFR—pharynx cancer	0.000406	0.00081	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ADH7—pharynx cancer	0.000404	0.000807	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—CDH1—pharynx cancer	0.000404	0.000806	CbGpPWpGaD
Ponatinib—LCK—Signaling by ERBB4—EGFR—pharynx cancer	0.000403	0.000805	CbGpPWpGaD
Ponatinib—LYN—B Cell Activation—EGFR—pharynx cancer	0.000403	0.000804	CbGpPWpGaD
Ponatinib—SRC—Senescence and Autophagy in Cancer—TP53—pharynx cancer	0.000403	0.000804	CbGpPWpGaD
Ponatinib—FGFR1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000391	0.000781	CbGpPWpGaD
Ponatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00039	0.000779	CbGpPWpGaD
Ponatinib—FGFR4—Adaptive Immune System—EGFR—pharynx cancer	0.000389	0.000777	CbGpPWpGaD
Ponatinib—LCK—Downstream signal transduction—EGFR—pharynx cancer	0.000385	0.000769	CbGpPWpGaD
Ponatinib—LCK—Signaling by FGFR—EGFR—pharynx cancer	0.000383	0.000765	CbGpPWpGaD
Ponatinib—LCK—Signaling by ERBB2—EGFR—pharynx cancer	0.000381	0.000761	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—CCND1—pharynx cancer	0.000381	0.00076	CbGpPWpGaD
Ponatinib—LCK—DAP12 signaling—EGFR—pharynx cancer	0.000379	0.000757	CbGpPWpGaD
Ponatinib—SRC—Signaling by SCF-KIT—EGFR—pharynx cancer	0.000379	0.000757	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000379	0.000756	CbGpPWpGaD
Ponatinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.000374	0.000746	CbGpPWpGaD
Ponatinib—SRC—Disease—B4GALT5—pharynx cancer	0.00037	0.000738	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CD79A—pharynx cancer	0.000369	0.000736	CbGpPWpGaD
Ponatinib—KIT—Immune System—CD79A—pharynx cancer	0.000362	0.000723	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CD79A—pharynx cancer	0.000362	0.000722	CbGpPWpGaD
Ponatinib—FGFR2—Signaling by NGF—EGFR—pharynx cancer	0.000362	0.000722	CbGpPWpGaD
Ponatinib—LCK—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000357	0.000713	CbGpPWpGaD
Ponatinib—LCK—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000357	0.000713	CbGpPWpGaD
Ponatinib—LCK—DAP12 interactions—EGFR—pharynx cancer	0.000357	0.000713	CbGpPWpGaD
Ponatinib—KIT—Signaling by NGF—EGFR—pharynx cancer	0.000355	0.000709	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ADH1B—pharynx cancer	0.000355	0.000708	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR—EGFR—pharynx cancer	0.000354	0.000706	CbGpPWpGaD
Ponatinib—LCK—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000351	0.0007	CbGpPWpGaD
Ponatinib—LCK—Signaling by PDGF—EGFR—pharynx cancer	0.000349	0.000697	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CD79A—pharynx cancer	0.000344	0.000686	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CD79A—pharynx cancer	0.000343	0.000685	CbGpPWpGaD
Ponatinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000342	0.000684	CbGpPWpGaD
Ponatinib—SRC—Downstream signal transduction—EGFR—pharynx cancer	0.000341	0.00068	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR—EGFR—pharynx cancer	0.000339	0.000677	CbGpPWpGaD
Ponatinib—SRC—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.000339	0.000677	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—B4GALT5—pharynx cancer	0.000339	0.000677	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—CDH1—pharynx cancer	0.000339	0.000676	CbGpPWpGaD
Ponatinib—SRC—Signaling by ERBB2—EGFR—pharynx cancer	0.000338	0.000674	CbGpPWpGaD
Ponatinib—FGFR1—Signaling by NGF—EGFR—pharynx cancer	0.000337	0.000673	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling by NGF—EGFR—pharynx cancer	0.000336	0.000671	CbGpPWpGaD
Ponatinib—SRC—TGF-beta Signaling Pathway—TP53—pharynx cancer	0.000335	0.00067	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—CDH1—pharynx cancer	0.000333	0.000664	CbGpPWpGaD
Ponatinib—LCK—B Cell Activation—EGFR—pharynx cancer	0.00033	0.000659	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CNDP2—pharynx cancer	0.00032	0.00064	CbGpPWpGaD
Ponatinib—LCK—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000316	0.000631	CbGpPWpGaD
Ponatinib—SRC—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000316	0.000631	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—CDH1—pharynx cancer	0.000316	0.00063	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—CDH1—pharynx cancer	0.000315	0.000629	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR—EGFR—pharynx cancer	0.000313	0.000625	CbGpPWpGaD
Ponatinib—SRC—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00031	0.00062	CbGpPWpGaD
Ponatinib—BCR—Disease—EGFR—pharynx cancer	0.00031	0.000618	CbGpPWpGaD
Ponatinib—SRC—Signaling by PDGF—EGFR—pharynx cancer	0.000309	0.000617	CbGpPWpGaD
Ponatinib—FGFR1—Axon guidance—EGFR—pharynx cancer	0.000305	0.000609	CbGpPWpGaD
Ponatinib—LYN—Immune System—CD79A—pharynx cancer	0.000302	0.000604	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CD79A—pharynx cancer	0.000301	0.000601	CbGpPWpGaD
Ponatinib—FGFR3—Innate Immune System—EGFR—pharynx cancer	0.0003	0.000599	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—CDH1—pharynx cancer	0.000299	0.000596	CbGpPWpGaD
Ponatinib—SRC—Focal Adhesion—EGFR—pharynx cancer	0.000299	0.000596	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000297	0.000594	CbGpPWpGaD
Ponatinib—KDR—Developmental Biology—EGFR—pharynx cancer	0.000296	0.000591	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ADH7—pharynx cancer	0.00029	0.000579	CbGpPWpGaD
Ponatinib—FGFR3—Adaptive Immune System—EGFR—pharynx cancer	0.000288	0.000575	CbGpPWpGaD
Ponatinib—SRC—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00028	0.000559	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—CDH1—pharynx cancer	0.000278	0.000555	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CNDP2—pharynx cancer	0.000278	0.000554	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—CCND1—pharynx cancer	0.000276	0.000552	CbGpPWpGaD
Ponatinib—LYN—Axon guidance—EGFR—pharynx cancer	0.000268	0.000536	CbGpPWpGaD
Ponatinib—ABL1—Axon guidance—EGFR—pharynx cancer	0.000267	0.000533	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ADH1B—pharynx cancer	0.000254	0.000507	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ADH7—pharynx cancer	0.000251	0.000501	CbGpPWpGaD
Ponatinib—SRC—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00025	0.000498	CbGpPWpGaD
Ponatinib—LCK—Immune System—CD79A—pharynx cancer	0.000248	0.000495	CbGpPWpGaD
Ponatinib—LCK—Signaling by NGF—EGFR—pharynx cancer	0.000243	0.000485	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—B4GALT5—pharynx cancer	0.000243	0.000485	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CNDP2—pharynx cancer	0.000242	0.000483	CbGpPWpGaD
Ponatinib—FGFR4—Immune System—EGFR—pharynx cancer	0.000236	0.000472	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CNDP2—pharynx cancer	0.000228	0.000455	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—CDH1—pharynx cancer	0.000228	0.000455	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.000224	0.000448	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ADH1B—pharynx cancer	0.00022	0.000439	CbGpPWpGaD
Ponatinib—SRC—Immune System—CD79A—pharynx cancer	0.000219	0.000438	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADH7—pharynx cancer	0.000219	0.000437	CbGpPWpGaD
Ponatinib—FGFR4—Disease—EGFR—pharynx cancer	0.000218	0.000435	CbGpPWpGaD
Ponatinib—FGFR1—Developmental Biology—EGFR—pharynx cancer	0.000218	0.000435	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—EGFR—pharynx cancer	0.000217	0.000433	CbGpPWpGaD
Ponatinib—SRC—Signaling by NGF—EGFR—pharynx cancer	0.000215	0.00043	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—B4GALT5—pharynx cancer	0.00021	0.00042	CbGpPWpGaD
Ponatinib—FGFR2—Innate Immune System—EGFR—pharynx cancer	0.000206	0.000412	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADH7—pharynx cancer	0.000206	0.000411	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—CDH1—pharynx cancer	0.000205	0.00041	CbGpPWpGaD
Ponatinib—KIT—Innate Immune System—EGFR—pharynx cancer	0.000203	0.000405	CbGpPWpGaD
Ponatinib—KIT—Immune System—CDH1—pharynx cancer	0.000202	0.000403	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—CDH1—pharynx cancer	0.000202	0.000402	CbGpPWpGaD
Ponatinib—FGFR2—Adaptive Immune System—EGFR—pharynx cancer	0.000198	0.000396	CbGpPWpGaD
Ponatinib—SRC—Axon guidance—EGFR—pharynx cancer	0.000195	0.000389	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—CCND1—pharynx cancer	0.000195	0.000389	CbGpPWpGaD
Ponatinib—KIT—Adaptive Immune System—EGFR—pharynx cancer	0.000195	0.000388	CbGpPWpGaD
Ponatinib—FGFR1—Innate Immune System—EGFR—pharynx cancer	0.000192	0.000384	CbGpPWpGaD
Ponatinib—PDGFRA—Innate Immune System—EGFR—pharynx cancer	0.000192	0.000383	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ADH1B—pharynx cancer	0.000192	0.000383	CbGpPWpGaD
Ponatinib—LYN—Developmental Biology—EGFR—pharynx cancer	0.000192	0.000382	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—CDH1—pharynx cancer	0.000192	0.000382	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—CDH1—pharynx cancer	0.000191	0.000381	CbGpPWpGaD
Ponatinib—ABL1—Developmental Biology—EGFR—pharynx cancer	0.000191	0.000381	CbGpPWpGaD
Ponatinib—FGFR1—Adaptive Immune System—EGFR—pharynx cancer	0.000185	0.000369	CbGpPWpGaD
Ponatinib—PDGFRA—Adaptive Immune System—EGFR—pharynx cancer	0.000184	0.000368	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—B4GALT5—pharynx cancer	0.000183	0.000366	CbGpPWpGaD
Ponatinib—BCR—Signaling Pathways—TP53—pharynx cancer	0.000182	0.000363	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ADH1B—pharynx cancer	0.000181	0.000361	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000176	0.000351	CbGpPWpGaD
Ponatinib—FGFR3—Immune System—EGFR—pharynx cancer	0.000175	0.000349	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—B4GALT5—pharynx cancer	0.000173	0.000345	CbGpPWpGaD
Ponatinib—LYN—Innate Immune System—EGFR—pharynx cancer	0.000169	0.000338	CbGpPWpGaD
Ponatinib—LYN—Immune System—CDH1—pharynx cancer	0.000169	0.000336	CbGpPWpGaD
Ponatinib—ABL1—Innate Immune System—EGFR—pharynx cancer	0.000168	0.000336	CbGpPWpGaD
Ponatinib—ABL1—Immune System—CDH1—pharynx cancer	0.000168	0.000335	CbGpPWpGaD
Ponatinib—LYN—Adaptive Immune System—EGFR—pharynx cancer	0.000162	0.000324	CbGpPWpGaD
Ponatinib—FGFR3—Disease—EGFR—pharynx cancer	0.000161	0.000322	CbGpPWpGaD
Ponatinib—LYN—Hemostasis—TP53—pharynx cancer	0.000158	0.000315	CbGpPWpGaD
Ponatinib—ABL1—Hemostasis—TP53—pharynx cancer	0.000157	0.000314	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—EGFR—pharynx cancer	0.000153	0.000305	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CNDP2—pharynx cancer	0.000149	0.000297	CbGpPWpGaD
Ponatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000148	0.000295	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—CCND1—pharynx cancer	0.000144	0.000287	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—EGFR—pharynx cancer	0.000139	0.000278	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—EGFR—pharynx cancer	0.000139	0.000277	CbGpPWpGaD
Ponatinib—LCK—Immune System—CDH1—pharynx cancer	0.000138	0.000276	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADH7—pharynx cancer	0.000135	0.000269	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—EGFR—pharynx cancer	0.000133	0.000266	CbGpPWpGaD
Ponatinib—LCK—Hemostasis—TP53—pharynx cancer	0.000129	0.000258	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—TP53—pharynx cancer	0.000128	0.000256	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—CCND1—pharynx cancer	0.000125	0.00025	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—EGFR—pharynx cancer	0.000123	0.000245	CbGpPWpGaD
Ponatinib—SRC—Immune System—CDH1—pharynx cancer	0.000122	0.000244	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—EGFR—pharynx cancer	0.00012	0.00024	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ADH1B—pharynx cancer	0.000118	0.000236	CbGpPWpGaD
Ponatinib—KIT—Immune System—EGFR—pharynx cancer	0.000118	0.000236	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—EGFR—pharynx cancer	0.000118	0.000235	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—TP53—pharynx cancer	0.000114	0.000229	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—EGFR—pharynx cancer	0.000113	0.000226	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—B4GALT5—pharynx cancer	0.000113	0.000225	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—EGFR—pharynx cancer	0.000112	0.000224	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—EGFR—pharynx cancer	0.000112	0.000223	CbGpPWpGaD
Ponatinib—FGFR2—Disease—EGFR—pharynx cancer	0.000111	0.000221	CbGpPWpGaD
Ponatinib—KIT—Disease—EGFR—pharynx cancer	0.000109	0.000218	CbGpPWpGaD
Ponatinib—FGFR1—Disease—EGFR—pharynx cancer	0.000103	0.000206	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—EGFR—pharynx cancer	0.000103	0.000206	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—CCND1—pharynx cancer	9.9e-05	0.000198	CbGpPWpGaD
Ponatinib—LYN—Immune System—EGFR—pharynx cancer	9.85e-05	0.000197	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—EGFR—pharynx cancer	9.84e-05	0.000196	CbGpPWpGaD
Ponatinib—ABL1—Immune System—EGFR—pharynx cancer	9.81e-05	0.000196	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—CCND1—pharynx cancer	9.73e-05	0.000194	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TP53—pharynx cancer	9.48e-05	0.000189	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CCND1—pharynx cancer	9.23e-05	0.000184	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CCND1—pharynx cancer	9.21e-05	0.000184	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TP53—pharynx cancer	8.26e-05	0.000165	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCND1—pharynx cancer	8.12e-05	0.000162	CbGpPWpGaD
Ponatinib—LCK—Immune System—EGFR—pharynx cancer	8.08e-05	0.000161	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—EGFR—pharynx cancer	7.77e-05	0.000155	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—EGFR—pharynx cancer	7.63e-05	0.000152	CbGpPWpGaD
Ponatinib—LCK—Disease—EGFR—pharynx cancer	7.46e-05	0.000149	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—EGFR—pharynx cancer	7.24e-05	0.000145	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—EGFR—pharynx cancer	7.22e-05	0.000144	CbGpPWpGaD
Ponatinib—SRC—Immune System—EGFR—pharynx cancer	7.15e-05	0.000143	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCND1—pharynx cancer	6.66e-05	0.000133	CbGpPWpGaD
Ponatinib—SRC—Disease—EGFR—pharynx cancer	6.6e-05	0.000132	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TP53—pharynx cancer	6.52e-05	0.00013	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TP53—pharynx cancer	6.41e-05	0.000128	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—EGFR—pharynx cancer	6.37e-05	0.000127	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TP53—pharynx cancer	6.08e-05	0.000121	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TP53—pharynx cancer	6.06e-05	0.000121	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCND1—pharynx cancer	5.89e-05	0.000118	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TP53—pharynx cancer	5.35e-05	0.000107	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—EGFR—pharynx cancer	5.22e-05	0.000104	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EGFR—pharynx cancer	4.62e-05	9.23e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TP53—pharynx cancer	4.38e-05	8.75e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TP53—pharynx cancer	3.88e-05	7.75e-05	CbGpPWpGaD
